Radiation exposure is a long-standing occupational concern in interventional cardiology, and a medical device radiation protection study announced by Egg Medical on 21 October 2026 claims that a table-mounted shielding system can cut staff doses sharply and support apron-optional work. The study, published in the Journal of the American Heart Association (JAHA) and run at The Christ Hospital in Cincinnati, is described only through the company’s release, so this report treats its figures as the company’s claims.
Key takeaways: the medical device radiation protection study at a glance
- Egg Medical says estimated annual collar dose for the primary operator fell from 86.7 mRem to 25.5 mRem with its EggNest Complete system (p < 0.001).
- The company says total effective doses for operators, scrub assistants and circulating nurses were 1% of the 5,000 mRem annual maximum it attributes to the ICRP.
- A second comparison reports 51.4 mRem with 0.5 mm lead aprons versus 1.4 mRem with 0.125 mm ultralight aprons plus EggNest Complete (p < 0.001).
- The Texas Department of State Health Services recently granted a variance to Methodist Healthcare System of San Antonio, per the release.
- Sample size, methods and limitations are not given, so this medical device radiation protection study cannot be read as proof for every lab.
Why radiation protection in catheterisation labs matters
General background: during fluoroscopy-guided procedures, the patient scatters part of the X-ray beam, and that scatter is the main source of exposure for the physicians and staff standing nearby. Operators therefore wear lead aprons and thyroid collars, and labs add ceiling-mounted and table-side shielding. The protection works, but heavy aprons are linked to back, neck and joint strain over a career, a point the company’s release emphasises.
Occupational dose guidance comes from bodies such as the International Commission on Radiological Protection, and national regulators set the legal limits. Interest in lead apron alternatives and better shielding has grown for that reason. This is background knowledge rather than a finding of the study.
What Egg Medical reports from the medical device radiation protection study
According to the company, the prospective, real-world study at The Christ Hospital compared standard shielding with heavy lead aprons against EggNest devices paired with ultralight aprons. The principal investigator, Dr. Santiago Garcia, is quoted saying the system protects the entire team so staff can choose to go apron-free. A second clinician quoted, Dr. Tim Henry, says he feels completely comfortable working apron-free. Both statements are opinions reported by the company.
The release does not give the number of procedures or operators, the measurement instruments, the study period or the limitations. The company site is at eggmedical.com and the full release is on GlobeNewswire. We looked for the JAHA paper, which is listed at ahajournals.org by journal, and did not find a direct listing.
Reading the dose benchmarks
The company compares doses with a 5,000 mRem annual maximum. That equals 50 mSv. By our arithmetic, 1% of that is about 50 mRem, a figure the release does not print. ICRP guidance also uses an average of 20 mSv a year over five years, so against that benchmark the same doses would be a different share. In this medical device radiation protection study the more informative comparison is within the study: 86.7 versus 25.5 mRem, about 71% lower by our calculation, and 51.4 versus 1.4 mRem, about 97% lower.
The Texas variance and what apron-optional means
The release says a state radiation variance was granted to Methodist Healthcare System of San Antonio. It gives no date and no terms. We have not seen the variance. The company describes its approach as apron-optional where approved, which is not the same as apron-free everywhere: the study compared EggNest with ultralight aprons, not with no apron, and any removal of aprons depends on local regulation and hospital policy.
Our analysis of the medical device radiation protection study: workplace safety, not a verdict
In our assessment, the medical device radiation protection study is best read as a promising signal about interventional cardiology workplace safety rather than a verdict. Extra shielding near the source can plausibly reduce staff dose, but the reduction in a different lab depends on layout, procedure mix and habits. The second comparison also changes apron weight and shielding together, which makes the contribution of the device itself harder to isolate.
For hospital safety committees, the useful next step is to ask for the dose tables, the dosimetry method and the number of cases. For readers, the key point is that a company release is the source here. See also Abbott Gets FDA Approval for CardioMEMS HF System Upgrade With CardioGuide HF App and our medical device coverage.
What is not disclosed about the medical device radiation protection study
- Procedure, operator and staff numbers.
- Dosimeter type, placement and study duration.
- The paper’s title, authors, DOI and limitations.
- Funding and author relationships with the company.
- The date and terms of the Texas variance.
Risks and caveats for the medical device radiation protection study
Company-sourced results tend to present the best case, and a statistically significant difference without a stated sample size cannot be fully interpreted. Results from one site do not establish the same outcome elsewhere. Dose is also a surrogate: the release makes no claim about health outcomes. Nothing here is medical or regulatory advice, and clinicians should rely on their radiation safety officers.
What to watch next for the medical device radiation protection study
- The published paper, including tables and limitations, for the medical device radiation protection study.
- Independent replication at other centres and in electrophysiology and structural heart procedures, which the company says are being evaluated elsewhere.
- Guidance from professional societies on apron-optional work.
FAQ
What did the medical device radiation protection study measure?
According to the company, it measured operator and staff radiation dose, including estimated annual collar dose and an effective dose estimate, with and without EggNest Complete.
Is radiation shielding in catheterisation labs changing?
The release points to a state variance in Texas, but one variance does not show a general shift. Practice varies by hospital and jurisdiction.
Where can I read the paper?
The release does not give a direct link. We did not locate it at the time of writing.
How we reported this: we read the company release and attributed every figure to Egg Medical. Calculations are labelled as ours. Last updated 23 October 2026. This is news reporting and not advice.
